ask="N/A"
ask_size="N/A"
average_daily_volume="1215410"
bid="N/A"
bid_size="N/A"
book_value="0.073"
change="+0.010"
change_from_200_day_moving_average="-0.022"
change_from_50_day_moving_average="0.027"
change_from_52_week_high="-0.236"
change_From_52_week_low="0.054"
change_in_percent="+5.747%"
close="0.184"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.057"
ebitda="-16.83M"
eps_estimate_current_year="-0.070"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.100"
ex_dividend_date="N/A"
float_shares="199244000"
high="0.204"
high_52_weeks="0.420"
last_trade_date="1/20/2017"
last_trade_price="0.184"
last_trade_size="1750"
last_trade_time="4:02pm"
low="0.175"
low_52_weeks="0.130"
market_capitalization="43.68M"
moving_average_200_day="0.206"
moving_average_50_day="0.157"
name="Rexahn Pharmaceuticals
Inc. Co"
notes="N/A"
one_year_target_price="2.500"
open="0.185"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-10.843%"
percent_change_from_50_day_moving_average="+17.220%"
percent_change_from_52_week_high="-56.190%"
percent_change_from_52_week_low="+41.538%"
previous_close="0.174"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.384"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="1.730"
stock_exchange="ASE"
symbol="RNN"
volume="6759546"
weeks_range_52="0.130 - 0.420"
